Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9BNC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,252
Award facts
- Contract value 100% obligated
- $10,251.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,251.99 firm fixed price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg, with an ultimate completion date of January 8, 2026. This non-set-aside delivery order was competitively awarded on December 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Venclexta is a targeted cancer therapy used primarily in hematologic malignancies, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated capability to fulfill federal medical procurement requirements through open competition, with a portfolio encompassing specialty medications, vaccines, and critical medical commodities.
Quick answers
Who was awarded contract SPE2DR26F9BNC?
SPE2DR26F9BNC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26F9BNC worth?
The government has obligated $10,252 on SPE2DR26F9BNC.
Is contract SPE2DR26F9BNC an order under another contract?
Yes. SPE2DR26F9BNC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BNC competed?
The extent of competition for SPE2DR26F9BNC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award